• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

长期接受阿片类药物治疗的退伍军人中的物质使用和使用障碍

Substance use and use disorders among Veterans on long-term opioid therapy.

作者信息

Ngo Thye Peng, Keyhani Salomeh, Leonard Samuel, Hoggatt Katherine J

机构信息

Center for Data to Discovery and Delivery Innovation (3DI), San Francisco VA Health Care System, CA, USA.

National Clinician Scholars Program (NCSP) at UCSF, San Francisco, CA, USA.

出版信息

Drug Alcohol Depend Rep. 2025 May 19;16:100347. doi: 10.1016/j.dadr.2025.100347. eCollection 2025 Sep.

DOI:10.1016/j.dadr.2025.100347
PMID:40520458
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12166433/
Abstract

BACKGROUND

Few studies have reported on the prevalence and health risks associated with substance use and substance use disorder (SU/SUD) in Veterans who use long-term opioid therapy (LTOT). We leveraged health record data to estimate SU/SUD prevalence and its association with mortality among Veterans on LTOT.

METHODS

We conducted a secondary analysis of cohort data for Veterans on LTOT within Veterans Health Administration outpatient settings (2014-2019). SU/SUD was defined as a positive screen for risky alcohol use; a positive urine drug screen for cannabis, benzodiazepines, or stimulants; or a documented SUD diagnosis. We fit Cox models for all-cause mortality, fatal overdose, and traumatic deaths, comparing Veterans on LTOT with SU/SUD vs. LTOT-only.

RESULTS

One in four (25.0 %) Veterans on LTOT have risky alcohol use, tested positive for other substances, or had a diagnosed SUD. Alcohol was the most common SU/SUD (9.8 %), followed by sedative (8.1 %), cannabis (6.6 %), and stimulant (0.6 %). Relative to Veterans on LTOT only, mortality rates were higher for Veterans on LTOT with cannabis (HR=1.16, 95 % CI=1.03, 1.30), sedative (HR=1.29, 95 % CI=1.10, 1.52), or stimulant SU/SUD (HR=1.54, 95 % CI=1.17, 2.02). Fatal overdose rates were higher for LTOT with alcohol (HR=1.43, 95 % CI=1.10, 1.86), sedatives (HR=1.40, 95 % CI=1.04, 1.91), or stimulant SU/SUD (HR=3.29, 95 % CI=1.60, 6.77). LTOT with sedative SU/SUD was associated with traumatic death rates (HR=1.30, 95 % CI=1.05, 1.61).

CONCLUSION

Substance co-use is common among Veterans on LTOT and is associated with elevated mortality and overdose risks. Comprehensive screening and targeted interventions may be needed.

摘要

背景

很少有研究报告长期使用阿片类药物治疗(LTOT)的退伍军人中物质使用及物质使用障碍(SU/SUD)的患病率和健康风险。我们利用健康记录数据来估计LTOT退伍军人中SU/SUD的患病率及其与死亡率的关联。

方法

我们对退伍军人健康管理局门诊环境中接受LTOT的退伍军人队列数据进行了二次分析(2014 - 2019年)。SU/SUD被定义为危险饮酒筛查呈阳性;大麻、苯二氮卓类药物或兴奋剂的尿液药物筛查呈阳性;或有记录的物质使用障碍诊断。我们对全因死亡率、致命过量用药和创伤性死亡拟合了Cox模型,比较了伴有SU/SUD的LTOT退伍军人与仅接受LTOT的退伍军人。

结果

接受LTOT的退伍军人中有四分之一(25.0%)存在危险饮酒、其他物质检测呈阳性或被诊断为物质使用障碍。酒精是最常见的SU/SUD(9.8%),其次是镇静剂(8.1%)、大麻(6.6%)和兴奋剂(0.6%)。与仅接受LTOT的退伍军人相比,使用大麻(HR = 1.16,95%CI = 1.03,1.30)、镇静剂(HR = 1.29,95%CI = 1.10,1.52)或兴奋剂SU/SUD的LTOT退伍军人死亡率更高。酒精(HR = 1.43,95%CI = 1.10,1.86)、镇静剂(HR = 1.40,95%CI = 1.04,1.91)或兴奋剂SU/SUD的LTOT致命过量用药率更高。伴有镇静剂SU/SUD的LTOT与创伤性死亡率相关(HR = 1.30,95%CI = 1.05,1.61)。

结论

物质共同使用在接受LTOT的退伍军人中很常见,并且与死亡率和过量用药风险升高相关。可能需要进行全面筛查和有针对性的干预。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d7da/12166433/396580de26e5/gr2a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d7da/12166433/f907955d5a96/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d7da/12166433/396580de26e5/gr2a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d7da/12166433/f907955d5a96/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d7da/12166433/396580de26e5/gr2a.jpg

相似文献

1
Substance use and use disorders among Veterans on long-term opioid therapy.长期接受阿片类药物治疗的退伍军人中的物质使用和使用障碍
Drug Alcohol Depend Rep. 2025 May 19;16:100347. doi: 10.1016/j.dadr.2025.100347. eCollection 2025 Sep.
2
The Effect of Substance Use Disorders on the Association Between Guideline-concordant Long-term Opioid Therapy and All-cause Mortality.物质使用障碍对符合指南的长期阿片类药物治疗与全因死亡率之间关联的影响。
J Addict Med. 2016 Nov/Dec;10(6):418-428. doi: 10.1097/ADM.0000000000000255.
3
Substance Use Disorder Treatment Following Clinician-Initiated Discontinuation of Long-Term Opioid Therapy Resulting from an Aberrant Urine Drug Test.临床医生因尿液药物检测异常而终止长期阿片类药物治疗后,对药物使用障碍的治疗。
J Gen Intern Med. 2017 Oct;32(10):1076-1082. doi: 10.1007/s11606-017-4084-0. Epub 2017 Jun 9.
4
Association of a Positive Drug Screening for Cannabis With Mortality and Hospital Visits Among Veterans Affairs Enrollees Prescribed Opioids.阿片类药物处方患者药物筛查呈阳性与退伍军人事务部患者的死亡率和住院就诊率的相关性研究。
JAMA Netw Open. 2022 Dec 1;5(12):e2247201. doi: 10.1001/jamanetworkopen.2022.47201.
5
The Association Between Receipt of Guideline-Concordant Long-Term Opioid Therapy and All-Cause Mortality.遵循指南的长期阿片类药物治疗与全因死亡率之间的关联。
J Gen Intern Med. 2016 May;31(5):492-501. doi: 10.1007/s11606-015-3571-4.
6
Trends in substance use disorder diagnoses among Veterans, 2009-2019.2009 年至 2019 年期间退伍军人物质使用障碍诊断的趋势。
Am J Addict. 2023 Jul;32(4):393-401. doi: 10.1111/ajad.13413. Epub 2023 Mar 8.
7
Trends in comorbid opioid and stimulant use disorders among Veterans receiving care from the Veterans Health Administration, 2005-2019.2005 年至 2019 年期间,在退伍军人事务部接受治疗的退伍军人中阿片类药物和兴奋剂共病使用障碍的趋势。
Drug Alcohol Depend. 2022 Mar 1;232:109310. doi: 10.1016/j.drugalcdep.2022.109310. Epub 2022 Jan 19.
8
Substance use disorders and COVID-19: An analysis of nation-wide Veterans Health Administration electronic health records.物质使用障碍与2019冠状病毒病:对退伍军人健康管理局全国电子健康记录的分析
Drug Alcohol Depend. 2022 May 1;234:109383. doi: 10.1016/j.drugalcdep.2022.109383. Epub 2022 Mar 3.
9
Polysubstance use and association with opioid use disorder treatment in the US Veterans Health Administration.美国退伍军人事务部的多药物使用与阿片类药物使用障碍治疗的关系。
Addiction. 2021 Jan;116(1):96-104. doi: 10.1111/add.15116. Epub 2020 Jul 7.
10
Alcohol-Related Care Among Veterans With Unhealthy Alcohol Use: The Role of Long-Term Opioid Therapy Receipt.慢性酒精使用的退伍军人中的酒精相关护理:长期阿片类药物治疗的作用。
J Addict Med. 2024;18(3):293-299. doi: 10.1097/ADM.0000000000001291. Epub 2024 Mar 27.

本文引用的文献

1
Peer specialist-led interventions in primary care at the Veterans Health Administration: An integrative review.退伍军人健康管理局基层医疗中由同伴专家主导的干预措施:一项综合综述。
Psychol Serv. 2025 May;22(2):256-269. doi: 10.1037/ser0000858. Epub 2024 Apr 11.
2
Alcohol-Related Care Among Veterans With Unhealthy Alcohol Use: The Role of Long-Term Opioid Therapy Receipt.慢性酒精使用的退伍军人中的酒精相关护理:长期阿片类药物治疗的作用。
J Addict Med. 2024;18(3):293-299. doi: 10.1097/ADM.0000000000001291. Epub 2024 Mar 27.
3
Long-term opioid therapy trajectories in veteran patients with and without substance use disorder.
有和没有物质使用障碍的退伍军人患者的长期阿片类药物治疗轨迹
Addict Behav. 2024 Jun;153:107997. doi: 10.1016/j.addbeh.2024.107997. Epub 2024 Feb 24.
4
Trends in co-prescribed opioids and benzodiazepines, non-prescribed opioids and benzodiazepines, and schedule-I drugs in the United States, 2013 to 2019.2013年至2019年美国联合开具阿片类药物和苯二氮䓬类药物、非处方阿片类药物和苯二氮䓬类药物以及附表一药物的趋势。
Prev Med Rep. 2023 Dec 29;38:102584. doi: 10.1016/j.pmedr.2023.102584. eCollection 2024 Feb.
5
Substance Use in U.S. Vietnam War Era Veterans and Nonveterans: Results from the Vietnam Era Health Retrospective Observational Study.美国越战时期退伍军人与非退伍军人的物质使用情况:越南时代健康回顾性观察研究的结果
Subst Use Misuse. 2023;58(7):858-870. doi: 10.1080/10826084.2023.2188427. Epub 2023 Apr 25.
6
Medical Costs of Substance Use Disorders in the US Employer-Sponsored Insurance Population.美国雇主赞助保险人群中物质使用障碍的医疗费用。
JAMA Netw Open. 2023 Jan 3;6(1):e2252378. doi: 10.1001/jamanetworkopen.2022.52378.
7
Association of a Positive Drug Screening for Cannabis With Mortality and Hospital Visits Among Veterans Affairs Enrollees Prescribed Opioids.阿片类药物处方患者药物筛查呈阳性与退伍军人事务部患者的死亡率和住院就诊率的相关性研究。
JAMA Netw Open. 2022 Dec 1;5(12):e2247201. doi: 10.1001/jamanetworkopen.2022.47201.
8
Concurrent use of opioids and stimulants and risk of fatal overdose: A cohort study.阿片类药物和兴奋剂同时使用与致命过量风险:队列研究。
BMC Public Health. 2022 Nov 15;22(1):2084. doi: 10.1186/s12889-022-14506-w.
9
Patient and Provider Perspectives on Benefits and Harms of Continuing, Tapering, and Discontinuing Long-Term Opioid Therapy.患者和提供者对长期阿片类药物治疗持续、逐渐减少和停止的获益和危害的看法。
J Gen Intern Med. 2023 Jun;38(8):1802-1811. doi: 10.1007/s11606-022-07880-z. Epub 2022 Nov 14.
10
CDC Clinical Practice Guideline for Prescribing Opioids for Pain - United States, 2022.美国疾病预防控制中心 2022 年《疼痛阿片类药物处方临床实践指南》。
MMWR Recomm Rep. 2022 Nov 4;71(3):1-95. doi: 10.15585/mmwr.rr7103a1.